CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure ...
Ipsen has become an active dealmaker as it pursues growth in oncology, and its latest move is the $450 million acquisition of Kartos Therapeutics, a clinical-stage biotech whose lead program could ...
A metabolic disorder that leads to high levels of fat in the blood and life-threatening pancreatic complications now has its first FDA-approved medicine, an RNA-targeting therapy developed by Ionis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results